Diagnostic arthroscopy versus arthrocentesis as initial treatment for arthralgia of the temporomandibular joint

Recruiting

• Conditions: Arthralgia, internal derangement and degenerative joint disease (i.e. osteoarthritis) of the temporomandibular joint

• Registration Number: NL-OMON20171
• Lead Sponsor: MCG

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 140

Inclusion Criteria

Patients aged > 18 years

- Arthralgia of the TMJ, proven with a diagnostic intra-articular injection with Ultracain DS Forte (articaine 4% + 1:100.000 adrenalin; Aventis Pharma, Hoevelaken, The Netherlands).

- TMJ pain still present after two weeks of NSAIDs (i.e. diclofenac 3 times daily 50mg)

- Symptoms presenting unilaterally or bilaterally with a maximal Visual Analog Scale (VAS)-score < 30 mm during movement or function of the contralateral joint, after anesthetizing the to be treated joint (thus avoiding the contralateral joint to be the cause of a limited mouth opening).

Exclusion Criteria

- Systemic rheumatic disease (such as rheumatoid arthritis, juvenile idiopathic arthritis, systemic lupus erythematosus, Sjögren syndromes, psoriatic arthritis)

- Connective tissue disease (such as Marfan syndrome, Ehlers-Danlos syndrome, Osteogenesis Imperfecta)

- Bony ankylosis of the TMJ

- Congenital or acquired dentofacial deformity

- History of jaw trauma that resulted in jaw or joint pain, bony changes or mandibular growth restriction

- Prior arthrocentesis, (diagnostic) arthroscopy or open-TMJ surgery

- Psychiatric disorder (as diagnosed by a physician)

- Unwillingness to receive one of the study treatments

- Pregnancy at time of treatment

- Concurrent use of steroids, sedatives, muscle relaxants or anti-inflammatory drugs other than the previously prescribed NSAIDs

- Incompetence to speak the Dutch or English language

- Medical comorbidities such as coagulation disorders, diabetes mellitus type I or II, kidney failure, heart failure, cardiac ischemia, hypertension and history of HIV.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain perceived by the patient during mandibular movement or function using the Visual Analogue Scale (VAS; ranging 0-100mm).